An Educational Opportunity for Clinicians Specializing in the Treatment of
Acute Coronary Syndrome (ACS)

Overview of ACS Formative Assessment CME Activity

Loading the player ...

Put your knowledge to the test and see how you stack up relative to your fellow clinicians! Challenge yourself with this self-paced interactive assessment designed to sharpen your knowledge and competency in risk stratification and triaging of patients for either conservative or invasive strategies, selecting appropriate antiplatelet therapy, and managing the variability of response to antiplatelet therapy.

Put your knowledge to the test and see how you stack up relative to your fellow clinicians.

Complete this assessment to obtain your personalized learning profile and earn CME credit

Challenge yourself with this self-paced activity that is chaired by thought leaders

Learning Objectives

Upon completion of this activity participants will be able to:

  • Apply evidence-based therapeutic interventions to facilitate initial and long-term treatment of ACS patients
  • Evaluate strategies for balancing the clinical benefits and risks of available and emerging antiplatelet therapies to improve ACS management and outcomes
  • Discuss how variability of response to antiplatelet therapy can impact ACS management
  • Implement new clinical findings and recommendations in ACS management to individualize therapy and improve patient adherence to treatment


Deepak L. Bhatt, MD, MPH (Chair) Type of financial relationships:

Advisory Board: Regado Biosciences

Research Grants: Amarin, AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Company, Eisai, Ethicon, Medtronic, Roche, Sanofi Aventis, and The Medicines Company

Discussion of Off-Label, Investigational, or Experimental Drug Use: Antiplatelet therapy – aspirin, clopidogrel, prasugrel, ticagrelor, cangrelor

Staff and Reviewer Disclosures

ACHL staff members and others involved with the planning, development, and review of the content for this activity have no relevant affiliations or financial relationships to disclose.


This activity is supported by an educational grant from Daiichi Sankyo, Inc. and Lilly USA, LLC.


Sponsored by the Academy for Continued Healthcare Learning